Reference is made to the stock exchange notice of Aqua Bio Technology ASA ("ABT" or the "Company") published on 14 February 2019, regarding independent subscription rights issued by the Company ("Warrants").
The exercise period for the Warrants ends on 1 September 2019, and exercise notices may be received by the Company until the end of that date. Warrants that are not exercised within the end of 1 September 2019 will lapse automatically without compensation to the holder.
Each Warrant gives the holder a right to subscribe for one (1) share in the Company at a subscription price of NOK 2.50 per share.
Holders of Warrants who wish to exercise these may do so by providing written notice to the Company, on the following address:
Aqua Bio Technology ASA
Fornebuveien 37
1366 Lysaker
Norway
E-mail: espen.kvale@aquabiotech.no
Investors who require issuance of shares through exercise of Warrants shall receive these as effectively as practically possible after 1 September 2019. The Company will provide payment information for share deposits following exercise of Warrants.
For further information, please contact Edvard Cock, Chairman of the Board, telephone +47 415 04 004 or eco@clp.no
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on the Axess market of the Oslo Stock Exchange.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.